(Q34680655)

3 August 2017

Pharmacokinetics and safety of oral posaconazole in neutropenic stem cell transplant recipients (English)

1 reference

stem cell transplantation

3 August 2017

1 reference

1 reference

Angela Sansone-Parsons

3

object named as

Angela Sansone-Parsons

0 references

author name string

Paul O Gubbins

1

1 reference

3 August 2017

Gopal Krishna

2

1 reference

3 August 2017

Angela Sansone-Parsons

3

1 reference

3 August 2017

Scott R Penzak

4

1 reference

3 August 2017

Li Dong

5

1 reference

3 August 2017

Monika Martinho

6

1 reference

3 August 2017

Elias J Anaissie

7

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 June 2006

1 reference

Antimicrobial Agents and Chemotherapy

3 August 2017

7

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

3 August 2017

50

1 reference

3 August 2017

6

1 reference

3 August 2017

1993-1999

1 reference

Pharmacokinetics, safety, and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infection

3 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1479147

Oral bioavailability of posaconazole in fasted healthy subjects: comparison between three regimens and basis for clinical dosage recommendations

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1479147

Disposition of posaconazole following single-dose oral administration in healthy subjects

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1479147

Posaconazole: a potent, extended-spectrum triazole anti-fungal for the treatment of serious fungal infections.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1479147

Pharmacokinetics of posaconazole coadministered with antacid in fasting or nonfasting healthy men

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1479147

Effect of food on the relative bioavailability of two oral formulations of posaconazole in healthy adults

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1479147

Pharmacokinetics, safety, and tolerability of oral posaconazole administered in single and multiple doses in healthy adults

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1479147

Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance P

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1479147

In vitro activities of posaconazole (Sch 56592) compared with those of itraconazole and fluconazole against 3,685 clinical isolates of Candida spp. and Cryptococcus neoformans

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1479147

Emerging fungal pathogens: evolving challenges to immunocompromised patients for the twenty-first century

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1479147

Drug, meal and formulation interactions influencing drug absorption after oral administration. Clinical implications

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1479147

Comparison of In vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1479147

A comparative study of the in vitro susceptibilities of clinical and laboratory-selected resistant isolates of Aspergillus spp. to amphotericin B, itraconazole, voriconazole and posaconazole (SCH 56592).

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1479147

Influence of concomitant food intake on the oral absorption of two triazole antifungal agents, itraconazole and fluconazole

26 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16723557

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

1 reference

https://pubmed.ncbi.nlm.nih.gov/16723557

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.00157-06

1 reference

3 August 2017

1 reference

3 August 2017

1 reference